Waverley Pharma Inc. (TSXV:WAVE)

Market Cap	1.35M -66.7%
Revenue (ttm)	1.25M +43.7%
Net Income	-628.60K
EPS	-0.01
Shares Out	54.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,730
Open	0.0250
Previous Close	0.0250
Day's Range	0.0250 - 0.0250
52-Week Range	0.0100 - 0.0400
Beta	1.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Waverley Pharma

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. In addition, it is involved in the sale of prescription medications, over-the-counter products, and associated pharmacy services. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: WAVE

Financial Performance

In 2025, Waverley Pharma's revenue was 1.35 million, an increase of 183.90% compared to the previous year's 475,373. Losses were -499,214, -47.29% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error